维普中文期刊产品整合服务
26篇 您的检索式:作者名="Gieschke"
    题名 作者 年代 出处 被引量
1Population pharmacokinetic analysis of the major metabolites of capecitabine显示文摘Gieschke R Reiger B Blesch K S 2002J Pharmacokinet Pharmacodyn2002,29,1:1
2Population Pharmacorkinetic analysis of the major metabolites of capecitabine显示文摘 Reigner B Blesch KS 2002J Pharmacokinet Pharmacodyn2002,29,1:1
3Clinical pharmacokinetic/pharmacodynamic and physiologically basedpharmacokinetic modeling in new drug development: The capecitabine experience显示文摘Blesch KS Gieschke R Tsukamoto Y 2003Investigation New Drugs2003,21,2:1
4Population pharmacokinetic analysis of the major metabolites of capecitabine 显示文摘Gieschke R Reigner B Blesch KS 2002J Pharmacokinet pharmacodyn2002,29,1:1
5Population Pharmacorkinetic analysis of the major metabolites of capecitabine显示文摘 Reigner B Blesch KS 2002J Pharmacokinet Pharmacodyn2002,29,1:1
6Population pharmacokinetic analysis of the major metabolites of capecitabine显示文摘Gieschke R Reigner B Blesch KS 2002J Pharmacokinet pharmacodyn2002,29,1:1
7Clinical pharmacokinetic/ pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development: the capecitabine experience显示文摘BLESCH KS GIESCHKE R TSUKAMOTO Y 2003Invest New Drugs2003,21,2:1
8Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol显示文摘van Steveninck A L Gieschke R Schoemaker R C 1996Br J Clin Pharmacol1996,41,6:1
9Population pharmacokinetics of ibandronate in Caucasian and Japanese healthy males and postmenopausal females显示文摘Pil ai G Gieschke R Goggin T 0,,12:1
10Exploring chinical study design by computer simulation based on pharmacokinetic/pharmacodynamic modelling显示文摘Gieschke R Reigner BG Steimer JL 1997Int J Clin Pharmacol Ther1997,35,:1
11Population phannacokinetics and concentration-effect relationships of capecitabine metabolites in colorectal cancer patients 显示文摘Gieschke R Burger HU Reigner B 2003Br J Clin Pharmacol2003,55,:1
12Clinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development:the capecitabine experience显示文摘Blesch KS Gieschke R Tsukamoto y 2003Invest New Drugs2003,21,2:1
13Population pharmacokinetic analysis of the major metabolites of capecitabine显示文摘Gieschke R Reigner B Blesch KS 2002J Pharmacokinet Pharmacodyn2002,29,1:1
14Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development显示文摘Gieschke R Steimer JL 2000Eur J Drug Metab Pharmacokinet2000,25,:1
15Population pharmacorkinetic analysis of the major metabolites of capecitabine 显示文摘Gieschke R Reigner B Blesch KS 2002J Pharmacokinet Pharmacodyn2002,29,1:1
16Population pharmacokinetics of ibandronate in Caucasian and Japanese healthy males and postmenopausal females显示文摘Pil ai G Gieschke R Goggin T 0,,12:1
17Population pharmacokinetic analysis of the major metabolites of capecitabine 显示文摘Gieschke R Reigner B Bleseh KS 2002J Pharmacokinet Pharmacodyn2002,29,1:1
18Spatially resolved measurement of magnetic flux density using a 32x32CMOS integrated hall sensor array显示文摘Stephan J M Gieschke P Paul O 2010Procedia Engineering2010,5,:1
19Spatially Resolved Measurement of Magnetic Flux Density Using a CMOS-Integrated HallSensor Array显示文摘STEPHAN J M GIESCHKE P 2010ProcediaEngineering2010,,5:1
20Clinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development:the capecitabine experience显示文摘Blesch KS Gieschke R Tsukamoto Y 2003Invest New Drugs2003,21,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费